Vanda Pharmaceuticals (VNDA) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.67% |
| Dec 31, 2025 | -36.65% |
| Sep 30, 2025 | -46.15% |
| Jun 30, 2025 | -31.42% |
| Mar 31, 2025 | 103.74% |
| Dec 31, 2024 | 32.92% |
| Sep 30, 2024 | 49.07% |
| Jun 30, 2024 | 1,442.86% |
| Mar 31, 2024 | -97.23% |
| Dec 31, 2023 | 954.17% |
| Sep 30, 2023 | -56.36% |
| Jun 30, 2023 | 7.84% |
| Mar 31, 2023 | -80.61% |
| Dec 31, 2022 | 77.70% |
| Sep 30, 2022 | -23.32% |
| Jun 30, 2022 | 157.33% |
| Mar 31, 2022 | -44.03% |
| Dec 31, 2021 | 1,440.00% |
| Sep 30, 2021 | -103.36% |
| Jun 30, 2021 | 129.23% |
| Mar 31, 2021 | -86.54% |
| Dec 31, 2020 | 292.68% |
| Sep 30, 2020 | 17.14% |
| Jun 30, 2020 | -43.70% |
| Mar 31, 2020 | 448.53% |
| Dec 31, 2019 | -76.87% |
| Sep 30, 2019 | 11.36% |
| Jun 30, 2019 | -32.82% |
| Mar 31, 2019 | 1,686.36% |
| Dec 31, 2018 | -83.82% |
| Sep 30, 2018 | 81.33% |
| Jun 30, 2018 | -44.44% |
| Mar 31, 2018 | -29.32% |
| Dec 31, 2017 | -48.52% |
| Sep 30, 2017 | -40.54% |
| Jun 30, 2017 | 30.54% |
| Mar 31, 2017 | -31.42% |
| Dec 31, 2016 | 16.36% |
| Dec 31, 2015 | -18.31% |
| Sep 30, 2015 | 460.26% |
| Jun 30, 2015 | -80.08% |
| Mar 31, 2015 | 131.66% |
| Dec 31, 2014 | 537.74% |
| Sep 30, 2014 | -78.19% |
| Jun 30, 2014 | 80.00% |
| Mar 31, 2014 | 39.18% |
| Dec 31, 2013 | 1,285.71% |
| Sep 30, 2013 | -85.71% |
| Jun 30, 2013 | 113.04% |
| Mar 31, 2013 | 228.57% |
| Dec 31, 2012 | -58.82% |
| Sep 30, 2012 | -88.51% |
| Jun 30, 2012 | -91.98% |
| Mar 31, 2012 | 2,296.10% |
| Dec 31, 2011 | 126.47% |